Fluticasone propionate compared with zafirlukast in controlling persistent asthma: A randomized double-blind, placebo-controlled trial

Journal of Family Practice

Volumn 50, Issue 7, 2001, Pages 595-602

  Busse, W ^a   Wolfe, J ^a   Storms, W ^a   Srebro, S ^a   Edwards, L ^a   Johnson, M ^a   Bowers, B W ^a   Rogenes, P R ^a   Rickard, K ^a  

^a University of Wisconsin Health   (United States)

Author keywords

Fluticasone propionate; Inhaled corticosteroids; Leukotriene modifier; Persistent asthma; Zafirlukast

Indexed keywords

FLUTICASONE PROPIONATE; PLACEBO; SALBUTAMOL; ZAFIRLUKAST;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; METERED DOSE INHALER; PEAK EXPIRATORY FLOW; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, INHALATION; ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; ANDROSTADIENES; ANTI-ASTHMATIC AGENTS; ANTI-INFLAMMATORY AGENTS; ASTHMA; CHILD; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LEUKOTRIENE ANTAGONISTS; MALE; MIDDLE AGED; PATIENT SATISFACTION; RESPIRATORY FUNCTION TESTS; TOSYL COMPOUNDS;

EID: 0034944843     PISSN: 00943509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma
2. Reference spirometric values using techniques and equipment that meet ATS recommendations
3. Reference values for lung function tests
4. Standardization of spirometry: A summary of recommendations from the American Thoracic Society. The 1987 update
5. Measuring quality of life in asthma
6. Determining a minimal important change in a disease-specific quality of life questionnaire
7. Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma
8. Zafirlukast for symptomatic mild-to-moderate asthma: A 13-week multicenter study
9. Time to onset of effect of fluticasone propionate in patients with asthma
10. 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma
11. Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics
12. Inhaled steroids and the risk of hospitalization for asthma
13. Acute and chronic effects of a 5-lipoxygenase inhibitor in asthma: A 6-month randomized multicenter trial
14. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma: A randomized, controlled trial
15. Fluticasone propionate aerosol: Efficacy in patients with mild to moderate asthma
16. Fluticasone propionate compared with theophylline for mild-to-moderate asthma
17. Therapeutic effect of zafirlukast as monotherapy in steroid-naive patients with severe persistent asthma
18. Efficacy and safety of inhaled corticosteroicts
19. Two weeks treatment with zafirlukast (Accolate), sodium cromoglycate or placebo on exercise-induced bronchoconstriction in asthmatic adolescents
20. The early onset of action of zafirlukast (Accolate) in patients with asthma
21. 2-agonists
22. Efficacy and duration of action of zafirlukast on cold air-induced bronchoconstriction in patients with asthma
23. The protective effect of zafirlukast against exercise-induced asthma
24. Leukotriene-receptor antagonists